Prior therapy should have included an anthracycline and a taxane in either the adjuvant or metastatic setting (1) See the full indication and important safety information for halaven®. Halaven is a microtubule inhibitor indicated for the treatment of patients with Metastatic breast cancer who have previously received at least two chemotherapeutic regimens for the treatment of metastatic disease Prior therapy should have included an anthracycline and a taxane in either the adjuvant or metastatic setting (1.1) unresectable or metastatic liposarcoma who have received a prior.
Full prescribing information indications and usage 1.1 metastatic breast cancer halaven is indicated for the treatment of patients with metastatic breast cancer who have previously received at least two chemotherapeutic regimens for the treatment of metastatic disease Prior therapy should have included an anthracycline and a taxane in either the adjuvant or metastatic setting [see clinical. Read a case study about a patient with metastatic breast cancer & visceral metastases View important safety information and prescribing information.
WATCH
